CN113749954A - Essence cream and preparation method thereof - Google Patents
Essence cream and preparation method thereof Download PDFInfo
- Publication number
- CN113749954A CN113749954A CN202010509153.4A CN202010509153A CN113749954A CN 113749954 A CN113749954 A CN 113749954A CN 202010509153 A CN202010509153 A CN 202010509153A CN 113749954 A CN113749954 A CN 113749954A
- Authority
- CN
- China
- Prior art keywords
- phase
- parts
- skin conditioner
- raw materials
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims description 31
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 80
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 65
- 239000002994 raw material Substances 0.000 claims abstract description 49
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims abstract description 38
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims abstract description 38
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000003974 emollient agent Substances 0.000 claims abstract description 28
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 27
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 27
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 26
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 26
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 20
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 20
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 20
- SCVVSSZVLZQUDZ-UHFFFAOYSA-N 3-methyl-2,6-dihydro-1H-pyrimidine-2-carboxylic acid Chemical compound CN1C(NCC=C1)C(=O)O SCVVSSZVLZQUDZ-UHFFFAOYSA-N 0.000 claims abstract description 19
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 102000008186 Collagen Human genes 0.000 claims abstract description 19
- 108010035532 Collagen Proteins 0.000 claims abstract description 19
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 19
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims abstract description 19
- 241000221095 Simmondsia Species 0.000 claims abstract description 19
- 235000004433 Simmondsia californica Nutrition 0.000 claims abstract description 19
- 229960003237 betaine Drugs 0.000 claims abstract description 19
- 229940082500 cetostearyl alcohol Drugs 0.000 claims abstract description 19
- 229920001436 collagen Polymers 0.000 claims abstract description 19
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 19
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940049964 oleate Drugs 0.000 claims abstract description 19
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 19
- 229940101267 panthenol Drugs 0.000 claims abstract description 19
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 19
- 239000011619 pantothenol Substances 0.000 claims abstract description 19
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229920000058 polyacrylate Polymers 0.000 claims abstract description 19
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940042585 tocopherol acetate Drugs 0.000 claims abstract description 19
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 19
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 18
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940046009 vitamin E Drugs 0.000 claims abstract description 18
- 239000011709 vitamin E Substances 0.000 claims abstract description 18
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 18
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims abstract description 14
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 12
- 244000179970 Monarda didyma Species 0.000 claims abstract description 11
- 235000010672 Monarda didyma Nutrition 0.000 claims abstract description 11
- 235000019198 oils Nutrition 0.000 claims abstract description 11
- 229960001484 edetic acid Drugs 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 61
- 238000003756 stirring Methods 0.000 claims description 42
- 235000011187 glycerol Nutrition 0.000 claims description 27
- -1 tetradecyl amino butyryl valinamide Chemical compound 0.000 claims description 22
- 238000010438 heat treatment Methods 0.000 claims description 21
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 14
- 238000004382 potting Methods 0.000 claims description 14
- 239000003921 oil Substances 0.000 claims description 10
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- USIVMVHZRCKJGX-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;urea Chemical compound NC(N)=O.OC(=O)C(F)(F)F USIVMVHZRCKJGX-UHFFFAOYSA-N 0.000 claims description 8
- 244000272459 Silybum marianum Species 0.000 claims description 8
- 235000010841 Silybum marianum Nutrition 0.000 claims description 8
- 230000032683 aging Effects 0.000 claims description 8
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 claims description 8
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 8
- 239000000839 emulsion Substances 0.000 claims description 8
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 8
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 8
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 7
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 7
- 229940106189 ceramide Drugs 0.000 claims description 7
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 7
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 7
- 229930182478 glucoside Natural products 0.000 claims description 7
- 150000008131 glucosides Chemical class 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 2
- 230000001815 facial effect Effects 0.000 abstract description 3
- 230000037303 wrinkles Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 230000002087 whitening effect Effects 0.000 description 6
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 5
- 229960005188 collagen Drugs 0.000 description 5
- 238000003892 spreading Methods 0.000 description 3
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229940093528 cetearyl ethylhexanoate Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses essence cream which comprises the following raw materials in percentage by weight: phase A: 2-5% of glycerol and 1-3% of hydrogenated lecithin; phase B: 3-6% of jojoba seed oil, 1-3% of 1, 2-pentanediol, 2-4% of cetostearyl alcohol, 0.5-2.5% of phytosterol oleate, 1-3% of emulsifier, 0.5-2% of tocopherol acetate, 0.5-1.5% of isostearic acid and 0.2-1% of vitamin E; and C phase: 2-8% of dipropylene glycol, 1-3% of betaine, 0.5-1.5% of emollient, 0.5-1.5% of skin conditioner I, 0.2-0.8% of panthenol, 0.6-1.2% of skin conditioner II, 0.3-0.6% of tetrahydro-methyl pyrimidine carboxylic acid, 0.5-1.2% of hydrolyzed collagen, 0.1-0.5% of sodium hyaluronate, 0.01-0.06% of disodium EDTA (ethylene diamine tetraacetic acid), 0.5-1.5% of polyacrylate cross-linked polymer, 0.2-1.0% of p-hydroxyacetophenone and 0.1-0.3% of bergamot fruit oil; the balance being water. According to the invention, the skin conditioner I and the skin conditioner II are added into the raw materials of the essence cream, so that the facial color spots of a user can be effectively removed, the wrinkles of the eyes and the corners of the user can be effectively reduced, and the essence cream is suitable for various skin groups and has a wide market prospect.
Description
Technical Field
The invention relates to the technical field of essence cream, and particularly relates to essence cream and a preparation method thereof.
Background
With age, the skin of people becomes gradually loose, and various spots and other problems are generated when the people are exposed to ultraviolet light, which troubles most people who love beauty. At present, whitening products on the market continuously emerge, but the effect is not satisfactory, some whitening products only cover flaws on the face to a certain extent, only some modifications are made on the outer part of the face, the symptoms and root causes are not cured, and more serious irreversible diseases are caused, namely the whitening products have undefined effect, adverse reactions and the like, so that the safety and skin care effect become the primary targets pursued by people.
Chinese patent CN106265331A discloses a skin-moistening and whitening cream, which comprises the following components in parts by weight: 1-10 parts of methyl glucoside sesquistearate, 1-5 parts of isononyl isononanoate, 1-5 parts of cetearyl ethyl hexanoate, 1-5 parts of cyclopenta dimethyl siloxane, 1-3 parts of dimethyl silicone oil, 1-5 parts of glycerol, 1-5 parts of butanediol, 0.5-1 part of carbomer, 0.05-0.1 part of EDTA (ethylene diamine tetraacetic acid), 0.5-1 part of allantoin, 1-3 parts of 3-O-ethyl ascorbic acid, 1-3 parts of lemon fruit extract, 1-2 parts of tocopheryl acetate, 1-2 parts of sodium acrylate, 1-3 parts of triethanolamine, 1-3 parts of sodium hyaluronate, 1-2 parts of ellagic acid, 1-2 parts of plant preservative and 40-80 parts of water. The patent achieves the effects of whitening skin, such as better light stability and higher water solubility, through the mutual synergistic effect among the components, but the effects of whitening skin, removing freckles and resisting aging are not obvious, and the increasing skin care requirements of people cannot be met.
Disclosure of Invention
The invention aims to provide essence cream and a preparation method thereof, and aims to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme:
the essence cream comprises the following raw materials in percentage by weight: phase A: 2-5% of glycerol and 1-3% of hydrogenated lecithin; phase B: 3-6% of jojoba seed oil, 1-3% of 1, 2-pentanediol, 2-4% of cetostearyl alcohol, 0.5-2.5% of phytosterol oleate, 1-3% of emulsifier, 0.5-2% of tocopherol acetate, 0.5-1.5% of isostearic acid and 0.2-1% of vitamin E; and C phase: 2-8% of dipropylene glycol, 1-3% of betaine, 0.5-1.5% of emollient, 0.5-1.5% of skin conditioner I, 0.2-0.8% of panthenol, 0.6-1.2% of skin conditioner II, 0.3-0.6% of tetrahydro-methyl pyrimidine carboxylic acid, 0.5-1.2% of hydrolyzed collagen, 0.1-0.5% of sodium hyaluronate, 0.01-0.06% of disodium EDTA (ethylene diamine tetraacetic acid), 0.5-1.5% of polyacrylate cross-linked polymer, 0.2-1.0% of p-hydroxyacetophenone and 0.1-0.3% of bergamot fruit oil; the balance being water.
As a further scheme of the invention: the composite material comprises the following raw materials in percentage by weight: phase A: 2-4% of glycerol and 1-2% of hydrogenated lecithin; phase B: 3-5% of jojoba seed oil, 2-3% of 1, 2-pentanediol, 2-3% of cetostearyl alcohol, 0.5-1.5% of phytosterol oleate, 1-2% of emulsifier, 0.5-1% of tocopherol acetate, 0.5-1% of isostearic acid and 0.2-0.5% of vitamin E; and C phase: 2-7% of dipropylene glycol, 1-2% of betaine, 0.5-1% of emollient, 0.5-1% of skin conditioner I, 0.2-0.6% of panthenol, 0.6-1% of skin conditioner II, 0.3-0.5% of tetrahydro-methyl pyrimidine carboxylic acid, 0.5-1% of hydrolyzed collagen, 0.1-0.3% of sodium hyaluronate, 0.02-0.06% of disodium EDTA (ethylene diamine tetraacetic acid), 0.8-1.5% of polyacrylate cross-linked polymer, 0.5-1.0% of p-hydroxyacetophenone and 0.2-0.3% of bergamot oil; the balance being water.
As a still further scheme of the invention: the composite material comprises the following raw materials in percentage by weight: phase A: 3% of glycerin and 1% of hydrogenated lecithin; phase B: 5% of jojoba seed oil, 2% of 1, 2-pentanediol, 2% of cetostearyl alcohol, 1.5% of phytosterol oleate, 1.5% of emulsifier, 0.5% of tocopherol acetate, 0.7% of isostearic acid and 0.5% of vitamin E; and C phase: 6% of dipropylene glycol, 2% of betaine, 0.8% of an emollient, 0.5% of a skin conditioner I, 0.5% of panthenol, 0.8% of a skin conditioner II, 0.5% of tetrahydro-methyl pyrimidinecarboxylic acid, 0.8% of hydrolyzed collagen, 0.1% of sodium hyaluronate, 0.05% of disodium EDTA, 0.8% of polyacrylate cross-linked polymer, 0.5% of p-hydroxyacetophenone and 0.2% of bergamot oil; the balance being water.
As a still further scheme of the invention: the emulsifier comprises the following raw materials in parts by weight: 5 parts of cetearyl alcohol and 8 parts of cetearyl glucoside.
As a still further scheme of the invention: the emollient comprises the following raw materials in parts by weight: 3 parts of tocopherol acetate, 5 parts of ceramide, 3 parts of hydrogenated lecithin and 4 parts of cholest.
As a still further scheme of the invention: the skin conditioner I comprises the following raw materials in parts by weight: 3 parts of tetradecyl amino butyryl valinamide butyric urea trifluoroacetate, 6 parts of glycerol, 10 parts of water and 2 parts of magnesium chloride.
As a still further scheme of the invention: the skin conditioner II comprises the following raw materials in parts by weight: 12 parts of water, 4 parts of butanediol and 3 parts of silybum marianum extract.
A preparation method of essence cream comprises the following steps:
s1, accurately weighing the raw materials;
s2, preparation of phase A: pouring the weighed glycerol and hydrogenated lecithin into a water phase pot, and heating to be completely mixed under stirring at the constant temperature of 70-75 ℃ to obtain a phase A mixture;
s3, preparation of phase B: pouring the weighed jojoba seed oil, 1, 2-pentanediol, cetostearyl alcohol, phytosterol oleate, an emulsifier, tocopheryl acetate, isostearic acid and vitamin E into another water phase pot, and heating to be completely mixed under the condition of constant temperature of 60-80 ℃ while stirring to obtain a B phase mixture;
s4, C phase preparation: pouring the weighed dipropylene glycol, betaine, emollient, skin conditioner I, panthenol, skin conditioner II, tetrahydro-methyl pyrimidine carboxylic acid, hydrolyzed collagen, sodium hyaluronate, disodium EDTA, polyacrylate cross-linked polymer, p-hydroxyacetophenone, bergamot fruit oil and half water into another water phase pot, and stirring and heating the mixture at the constant temperature of 65-85 ℃ until the mixture is completely mixed to obtain a C-phase mixture;
s5, three-phase mixing: and quickly pouring the mixture of the phase A and the mixture of the phase B into the mixture of the phase C, vigorously stirring to form emulsion, continuously and slowly stirring and cooling to 40-50 ℃, adding the residual water, continuously stirring and cooling to room temperature, and standing and aging at the temperature of 20-30 ℃ for 2-4 days to obtain the essence cream.
Compared with the prior art, the invention has the beneficial effects that: according to the invention, the skin conditioner I and the skin conditioner II are added to the raw materials of the essence cream, the skin conditioner I comprises tetradecyl aminobutyroylvalerian amidobutyric urea trifluoroacetate, glycerin, water and magnesium chloride, and the skin conditioner II comprises water, butanediol and silybum marianum extracts, so that the facial color spots of a user can be effectively removed, the wrinkles of the eyes of the user can be effectively reduced, and the essence cream is suitable for various skin crowds and has a wide market prospect.
Detailed Description
The technical solution of the present invention will be described in further detail with reference to specific embodiments.
Example 1
The essence cream comprises the following raw materials in percentage by weight: phase A: 2% of glycerol and 1% of hydrogenated lecithin; phase B: 3% of jojoba seed oil, 1% of 1, 2-pentanediol, 2% of cetostearyl alcohol, 0.5% of phytosterol oleate, 1% of emulsifier, 0.5% of tocopherol acetate, 0.5% of isostearic acid and 0.2% of vitamin E; and C phase: 2% of dipropylene glycol, 1% of betaine, 0.5% of an emollient, 0.5% of a skin conditioner I, 0.2% of panthenol, 0.6% of a skin conditioner II, 0.3% of tetrahydro-methyl pyrimidinecarboxylic acid, 0.5% of hydrolyzed collagen, 0.1% of sodium hyaluronate, 0.01% of disodium EDTA, 0.5% of polyacrylate cross-linked polymer, 0.2% of p-hydroxyacetophenone and 0.1% of bergamot oil; the balance being water.
Specifically, in this embodiment: the emulsifier comprises the following raw materials in parts by weight: 5 parts of cetearyl alcohol and 8 parts of cetearyl glucoside.
Specifically, in this embodiment: the emollient comprises the following raw materials in parts by weight: 3 parts of tocopherol acetate, 5 parts of ceramide, 3 parts of hydrogenated lecithin and 4 parts of cholest.
Specifically, in this embodiment: the skin conditioner I comprises the following raw materials in parts by weight: 3 parts of tetradecyl amino butyryl valinamide butyric urea trifluoroacetate, 6 parts of glycerol, 10 parts of water and 2 parts of magnesium chloride.
Specifically, in this embodiment: the skin conditioner II comprises the following raw materials in parts by weight: 12 parts of water, 4 parts of butanediol and 3 parts of silybum marianum extract.
A preparation method of essence cream comprises the following steps:
s1, accurately weighing the raw materials;
s2, preparation of phase A: pouring the weighed glycerol and hydrogenated lecithin into a water phase pot, and heating the mixture to be completely mixed under stirring at the constant temperature of 70 ℃ to obtain a phase A mixture;
s3, preparation of phase B: pouring the weighed jojoba seed oil, 1, 2-pentanediol, cetostearyl alcohol, phytosterol oleate, an emulsifier, tocopheryl acetate, isostearic acid and vitamin E into another water phase pot, and heating to be completely mixed under the condition of constant temperature of 60 ℃ while stirring to obtain a B phase mixture;
s4, C phase preparation: pouring the weighed dipropylene glycol, betaine, emollient, skin conditioner I, panthenol, skin conditioner II, tetrahydro-methyl pyrimidine carboxylic acid, hydrolyzed collagen, sodium hyaluronate, EDTA disodium, polyacrylate cross-linked polymer, p-hydroxyacetophenone, bergamot fruit oil and half water into another water phase pot, and stirring and heating the mixture at the constant temperature of 65 ℃ until the mixture is completely mixed to obtain a C-phase mixture;
s5, three-phase mixing: and quickly pouring the mixture of the phase A and the mixture of the phase B into the mixture of the phase C, vigorously stirring to form emulsion, continuously and slowly stirring and cooling to 40 ℃, adding the residual water, continuously stirring and cooling to room temperature, and standing and aging for 2 days at the temperature of 20 ℃ to obtain the essence cream.
Example 2
The essence cream comprises the following raw materials in percentage by weight: phase A: 5% of glycerol and 3% of hydrogenated lecithin; phase B: jojoba seed oil 6%, 1, 2-pentanediol 3%, cetostearyl alcohol 4%, phytosterol oleate 2.5%, emulsifier 3%, tocopherol acetate 2%, isostearic acid 1.5%, and vitamin E1%; and C phase: 8% of dipropylene glycol, 3% of betaine, 1.5% of an emollient, 1.5% of a skin conditioner I, 0.8% of panthenol, 1.2% of a skin conditioner II, 0.6% of tetrahydro-methyl pyrimidinecarboxylic acid, 1.2% of hydrolyzed collagen, 0.5% of sodium hyaluronate, 0.06% of disodium EDTA, 1.5% of polyacrylate cross-linked polymer, 1.0% of p-hydroxyacetophenone and 0.3% of bergamot oil; the balance being water.
Specifically, in this embodiment: the emulsifier comprises the following raw materials in parts by weight: 5 parts of cetearyl alcohol and 8 parts of cetearyl glucoside.
Specifically, in this embodiment: the emollient comprises the following raw materials in parts by weight: 3 parts of tocopherol acetate, 5 parts of ceramide, 3 parts of hydrogenated lecithin and 4 parts of cholest.
Specifically, in this embodiment: the skin conditioner I comprises the following raw materials in parts by weight: 3 parts of tetradecyl amino butyryl valinamide butyric urea trifluoroacetate, 6 parts of glycerol, 10 parts of water and 2 parts of magnesium chloride.
Specifically, in this embodiment: the skin conditioner II comprises the following raw materials in parts by weight: 12 parts of water, 4 parts of butanediol and 3 parts of silybum marianum extract.
A preparation method of essence cream comprises the following steps:
s1, accurately weighing the raw materials;
s2, preparation of phase A: pouring the weighed glycerol and hydrogenated lecithin into a water phase pot, and heating the mixture to be completely mixed under stirring at the constant temperature of 75 ℃ to obtain a phase A mixture;
s3, preparation of phase B: pouring the weighed jojoba seed oil, 1, 2-pentanediol, cetostearyl alcohol, phytosterol oleate, an emulsifier, tocopheryl acetate, isostearic acid and vitamin E into another water phase pot, and heating to be completely mixed under the condition of constant temperature of 80 ℃ while stirring to obtain a B phase mixture;
s4, C phase preparation: pouring the weighed dipropylene glycol, betaine, emollient, skin conditioner I, panthenol, skin conditioner II, tetrahydro-methyl pyrimidine carboxylic acid, hydrolyzed collagen, sodium hyaluronate, EDTA disodium, polyacrylate cross-linked polymer, p-hydroxyacetophenone, bergamot fruit oil and half water into another water phase pot, and stirring and heating the mixture at the constant temperature of 85 ℃ until the mixture is completely mixed to obtain a C-phase mixture;
s5, three-phase mixing: and quickly pouring the mixture of the phase A and the mixture of the phase B into the mixture of the phase C, vigorously stirring to form emulsion, continuously and slowly stirring and cooling to 50 ℃, adding the residual water, continuously stirring and cooling to room temperature, and standing and aging for 4 days at the temperature of 30 ℃ to obtain the essence cream.
Example 3
The essence cream comprises the following raw materials in percentage by weight: phase A: 2% of glycerol and 1% of hydrogenated lecithin; phase B: 3% of jojoba seed oil, 2% of 1, 2-pentanediol, 2% of cetostearyl alcohol, 0.5% of phytosterol oleate, 1% of emulsifier, 0.5% of tocopherol acetate, 0.5% of isostearic acid and 0.2% of vitamin E; and C phase: 2% of dipropylene glycol, 1% of betaine, 0.5% of an emollient, 0.5% of a skin conditioner I, 0.2% of panthenol, 0.6% of a skin conditioner II, 0.3% of tetrahydro-methyl pyrimidinecarboxylic acid, 0.5% of hydrolyzed collagen, 0.1% of sodium hyaluronate, 0.02% of disodium EDTA, 0.8% of polyacrylate cross-linked polymer, 0.5% of p-hydroxyacetophenone and 0.2% of bergamot oil; the balance being water.
Specifically, in this embodiment: the emulsifier comprises the following raw materials in parts by weight: 5 parts of cetearyl alcohol and 8 parts of cetearyl glucoside.
Specifically, in this embodiment: the emollient comprises the following raw materials in parts by weight: 3 parts of tocopherol acetate, 5 parts of ceramide, 3 parts of hydrogenated lecithin and 4 parts of cholest.
Specifically, in this embodiment: the skin conditioner I comprises the following raw materials in parts by weight: 3 parts of tetradecyl amino butyryl valinamide butyric urea trifluoroacetate, 6 parts of glycerol, 10 parts of water and 2 parts of magnesium chloride.
Specifically, in this embodiment: the skin conditioner II comprises the following raw materials in parts by weight: 12 parts of water, 4 parts of butanediol and 3 parts of silybum marianum extract.
A preparation method of essence cream comprises the following steps:
s1, accurately weighing the raw materials;
s2, preparation of phase A: pouring the weighed glycerol and hydrogenated lecithin into a water phase pot, and heating the mixture to be completely mixed under stirring at the constant temperature of 70 ℃ to obtain a phase A mixture;
s3, preparation of phase B: pouring the weighed jojoba seed oil, 1, 2-pentanediol, cetostearyl alcohol, phytosterol oleate, an emulsifier, tocopheryl acetate, isostearic acid and vitamin E into another water phase pot, and heating to be completely mixed under the condition of constant temperature of 60 ℃ while stirring to obtain a B phase mixture;
s4, C phase preparation: pouring the weighed dipropylene glycol, betaine, emollient, skin conditioner I, panthenol, skin conditioner II, tetrahydro-methyl pyrimidine carboxylic acid, hydrolyzed collagen, sodium hyaluronate, EDTA disodium, polyacrylate cross-linked polymer, p-hydroxyacetophenone, bergamot fruit oil and half water into another water phase pot, and stirring and heating the mixture at the constant temperature of 65 ℃ until the mixture is completely mixed to obtain a C-phase mixture;
s5, three-phase mixing: and quickly pouring the mixture of the phase A and the mixture of the phase B into the mixture of the phase C, vigorously stirring to form emulsion, continuously and slowly stirring and cooling to 40 ℃, adding the residual water, continuously stirring and cooling to room temperature, and standing and aging for 2 days at the temperature of 20 ℃ to obtain the essence cream.
Example 4
The essence cream comprises the following raw materials in percentage by weight: phase A: 4% of glycerol and 2% of hydrogenated lecithin; phase B: 5% of jojoba seed oil, 3% of 1, 2-pentanediol, 3% of cetostearyl alcohol, 1.5% of phytosterol oleate, 2% of emulsifier, 1% of tocopherol acetate, 1% of isostearic acid and 0.5% of vitamin E; and C phase: 7% of dipropylene glycol, 2% of betaine, 1% of an emollient, 1% of a skin conditioner I, 0.6% of panthenol, 1% of a skin conditioner II, 0.5% of tetrahydro-methyl pyrimidinecarboxylic acid, 1% of hydrolyzed collagen, 0.3% of sodium hyaluronate, 0.06% of disodium EDTA, 1.5% of polyacrylate cross-linked polymer, 1.0% of p-hydroxyacetophenone and 0.3% of bergamot fruit oil; the balance being water.
Specifically, in this embodiment: the emulsifier comprises the following raw materials in parts by weight: 5 parts of cetearyl alcohol and 8 parts of cetearyl glucoside.
Specifically, in this embodiment: the emollient comprises the following raw materials in parts by weight: 3 parts of tocopherol acetate, 5 parts of ceramide, 3 parts of hydrogenated lecithin and 4 parts of cholest.
Specifically, in this embodiment: the skin conditioner I comprises the following raw materials in parts by weight: 3 parts of tetradecyl amino butyryl valinamide butyric urea trifluoroacetate, 6 parts of glycerol, 10 parts of water and 2 parts of magnesium chloride.
Specifically, in this embodiment: the skin conditioner II comprises the following raw materials in parts by weight: 12 parts of water, 4 parts of butanediol and 3 parts of silybum marianum extract.
A preparation method of essence cream comprises the following steps:
s1, accurately weighing the raw materials;
s2, preparation of phase A: pouring the weighed glycerol and hydrogenated lecithin into a water phase pot, and heating the mixture to be completely mixed under stirring at the constant temperature of 75 ℃ to obtain a phase A mixture;
s3, preparation of phase B: pouring the weighed jojoba seed oil, 1, 2-pentanediol, cetostearyl alcohol, phytosterol oleate, an emulsifier, tocopheryl acetate, isostearic acid and vitamin E into another water phase pot, and heating to be completely mixed under the condition of constant temperature of 80 ℃ while stirring to obtain a B phase mixture;
s4, C phase preparation: pouring the weighed dipropylene glycol, betaine, emollient, skin conditioner I, panthenol, skin conditioner II, tetrahydro-methyl pyrimidine carboxylic acid, hydrolyzed collagen, sodium hyaluronate, EDTA disodium, polyacrylate cross-linked polymer, p-hydroxyacetophenone, bergamot fruit oil and half water into another water phase pot, and stirring and heating the mixture at the constant temperature of 85 ℃ until the mixture is completely mixed to obtain a C-phase mixture;
s5, three-phase mixing: and quickly pouring the mixture of the phase A and the mixture of the phase B into the mixture of the phase C, vigorously stirring to form emulsion, continuously and slowly stirring and cooling to 50 ℃, adding the residual water, continuously stirring and cooling to room temperature, and standing and aging for 4 days at the temperature of 30 ℃ to obtain the essence cream.
Example 5
The essence cream comprises the following raw materials in percentage by weight: phase A: 3% of glycerin and 1% of hydrogenated lecithin; phase B: 5% of jojoba seed oil, 2% of 1, 2-pentanediol, 2% of cetostearyl alcohol, 1.5% of phytosterol oleate, 1.5% of emulsifier, 0.5% of tocopherol acetate, 0.7% of isostearic acid and 0.5% of vitamin E; and C phase: 6% of dipropylene glycol, 2% of betaine, 0.8% of an emollient, 0.5% of a skin conditioner I, 0.5% of panthenol, 0.8% of a skin conditioner II, 0.5% of tetrahydro-methyl pyrimidinecarboxylic acid, 0.8% of hydrolyzed collagen, 0.1% of sodium hyaluronate, 0.05% of disodium EDTA, 0.8% of polyacrylate cross-linked polymer, 0.5% of p-hydroxyacetophenone and 0.2% of bergamot oil; the balance being water.
Specifically, in this embodiment: the emulsifier comprises the following raw materials in parts by weight: 5 parts of cetearyl alcohol and 8 parts of cetearyl glucoside.
Specifically, in this embodiment: the emollient comprises the following raw materials in parts by weight: 3 parts of tocopherol acetate, 5 parts of ceramide, 3 parts of hydrogenated lecithin and 4 parts of cholest.
Specifically, in this embodiment: the skin conditioner I comprises the following raw materials in parts by weight: 3 parts of tetradecyl amino butyryl valinamide butyric urea trifluoroacetate, 6 parts of glycerol, 10 parts of water and 2 parts of magnesium chloride.
Specifically, in this embodiment: the skin conditioner II comprises the following raw materials in parts by weight: 12 parts of water, 4 parts of butanediol and 3 parts of silybum marianum extract.
A preparation method of essence cream comprises the following steps:
s1, accurately weighing the raw materials;
s2, preparation of phase A: pouring the weighed glycerol and hydrogenated lecithin into a water phase pot, and heating the mixture to be completely mixed under stirring at the constant temperature of 75 ℃ to obtain a phase A mixture;
s3, preparation of phase B: pouring the weighed jojoba seed oil, 1, 2-pentanediol, cetostearyl alcohol, phytosterol oleate, an emulsifier, tocopheryl acetate, isostearic acid and vitamin E into another water phase pot, and heating to be completely mixed under the condition of constant temperature of 70 ℃ while stirring to obtain a B phase mixture;
s4, C phase preparation: pouring the weighed dipropylene glycol, betaine, emollient, skin conditioner I, panthenol, skin conditioner II, tetrahydro-methyl pyrimidine carboxylic acid, hydrolyzed collagen, sodium hyaluronate, EDTA disodium, polyacrylate cross-linked polymer, p-hydroxyacetophenone, bergamot fruit oil and half water into another water phase pot, and stirring and heating the mixture at the constant temperature of 75 ℃ until the mixture is completely mixed to obtain a C-phase mixture;
s5, three-phase mixing: and quickly pouring the mixture of the phase A and the mixture of the phase B into the mixture of the phase C, vigorously stirring to form emulsion, continuously and slowly stirring and cooling to 45 ℃, then adding the residual water, continuously stirring and cooling to room temperature, and standing and aging for 3 days at the temperature of 20 ℃ to obtain the essence cream.
Comparative example 1
Compared with example 5, the emulsion and the emollient are not contained, and the rest is the same as example 5.
Comparative example 2
In comparison with example 5, the skin conditioner I and the skin conditioner II were not contained, and the other examples were the same as example 5.
Comparative example 3
Compared with example 5, the skin conditioner I and the skin conditioner II do not contain emulsifier, emollient and the rest are the same as example 5.
Skin care test experiment
Randomly selecting 200 persons for testing, and randomly dividing 200 persons into four groups, wherein each group comprises 50 persons, the first group applies the essence cream prepared in the embodiment 5 on the face, the second group applies the essence cream prepared in the comparative example 1 on the same position of the face, the third group applies the essence cream prepared in the comparative example 2 on the same position of the face, and the fourth group applies the essence cream prepared in the comparative example on the same position of the face, wherein the applying method comprises the following steps: spreading the cream on the face by five points, spreading a proper amount of essence cream on the face, lifting the cream upwards in a massage mode, observing and counting the result after spreading for 30min, wherein the specific result is shown in table 1:
TABLE 1 Experimental results Table
From the results, the essence cream prepared by the invention can eliminate facial stains and wrinkles at the corners of eyes, has rapid effect and obvious effect, and meanwhile, the comparison of the data of the example 3 and the comparative examples 1-3 shows that the skin conditioner I and the skin conditioner II added in the essence cream can effectively improve the skin care effect of the essence cream.
While the preferred embodiments of the present invention have been described in detail, the present invention is not limited to the above embodiments, and various changes can be made without departing from the spirit of the present invention within the knowledge of those skilled in the art.
Claims (8)
1. The essence cream is characterized by comprising the following raw materials in percentage by weight:
phase A: 2-5% of glycerol and 1-3% of hydrogenated lecithin;
phase B: 3-6% of jojoba seed oil, 1-3% of 1, 2-pentanediol, 2-4% of cetostearyl alcohol, 0.5-2.5% of phytosterol oleate, 1-3% of emulsifier, 0.5-2% of tocopherol acetate, 0.5-1.5% of isostearic acid and 0.2-1% of vitamin E;
and C phase: 2-8% of dipropylene glycol, 1-3% of betaine, 0.5-1.5% of emollient, 0.5-1.5% of skin conditioner I, 0.2-0.8% of panthenol, 0.6-1.2% of skin conditioner II, 0.3-0.6% of tetrahydro-methyl pyrimidine carboxylic acid, 0.5-1.2% of hydrolyzed collagen, 0.1-0.5% of sodium hyaluronate, 0.01-0.06% of disodium EDTA (ethylene diamine tetraacetic acid), 0.5-1.5% of polyacrylate cross-linked polymer, 0.2-1.0% of p-hydroxyacetophenone and 0.1-0.3% of bergamot fruit oil;
the balance being water.
2. The essence cream of claim 1, characterized by comprising the following raw materials in percentage by weight:
phase A: 2-4% of glycerol and 1-2% of hydrogenated lecithin;
phase B: 3-5% of jojoba seed oil, 2-3% of 1, 2-pentanediol, 2-3% of cetostearyl alcohol, 0.5-1.5% of phytosterol oleate, 1-2% of emulsifier, 0.5-1% of tocopherol acetate, 0.5-1% of isostearic acid and 0.2-0.5% of vitamin E;
and C phase: 2-7% of dipropylene glycol, 1-2% of betaine, 0.5-1% of emollient, 0.5-1% of skin conditioner I, 0.2-0.6% of panthenol, 0.6-1% of skin conditioner II, 0.3-0.5% of tetrahydro-methyl pyrimidine carboxylic acid, 0.5-1% of hydrolyzed collagen, 0.1-0.3% of sodium hyaluronate, 0.02-0.06% of disodium EDTA (ethylene diamine tetraacetic acid), 0.8-1.5% of polyacrylate cross-linked polymer, 0.5-1.0% of p-hydroxyacetophenone and 0.2-0.3% of bergamot oil;
the balance being water.
3. The essence cream of claim 2, characterized by comprising the following raw materials in percentage by weight:
phase A: 3% of glycerin and 1% of hydrogenated lecithin;
phase B: 5% of jojoba seed oil, 2% of 1, 2-pentanediol, 2% of cetostearyl alcohol, 1.5% of phytosterol oleate, 1.5% of emulsifier, 0.5% of tocopherol acetate, 0.7% of isostearic acid and 0.5% of vitamin E;
and C phase: 6% of dipropylene glycol, 2% of betaine, 0.8% of an emollient, 0.5% of a skin conditioner I, 0.5% of panthenol, 0.8% of a skin conditioner II, 0.5% of tetrahydro-methyl pyrimidinecarboxylic acid, 0.8% of hydrolyzed collagen, 0.1% of sodium hyaluronate, 0.05% of disodium EDTA, 0.8% of polyacrylate cross-linked polymer, 0.5% of p-hydroxyacetophenone and 0.2% of bergamot oil;
the balance being water.
4. The essence cream of claim 3, wherein the emulsifier comprises the following raw materials in parts by weight: 5 parts of cetearyl alcohol and 8 parts of cetearyl glucoside.
5. The essence cream of claim 4, wherein the emollient comprises the following raw materials in parts by weight: 3 parts of tocopherol acetate, 5 parts of ceramide, 3 parts of hydrogenated lecithin and 4 parts of cholest.
6. The essence cream of claim 5, wherein the skin conditioner I comprises the following raw materials in parts by weight: 3 parts of tetradecyl amino butyryl valinamide butyric urea trifluoroacetate, 6 parts of glycerol, 10 parts of water and 2 parts of magnesium chloride.
7. The essence cream of claim 6, wherein the skin conditioner II comprises the following raw materials in parts by weight: 12 parts of water, 4 parts of butanediol and 3 parts of silybum marianum extract.
8. The method for preparing the essence cream according to any one of claims 1 to 7, comprising the steps of:
s1, accurately weighing the raw materials;
s2, preparation of phase A: pouring the weighed glycerol and hydrogenated lecithin into a water phase pot, and heating to be completely mixed under stirring at the constant temperature of 70-75 ℃ to obtain a phase A mixture;
s3, preparation of phase B: pouring the weighed jojoba seed oil, 1, 2-pentanediol, cetostearyl alcohol, phytosterol oleate, an emulsifier, tocopheryl acetate, isostearic acid and vitamin E into another water phase pot, and heating to be completely mixed under the condition of constant temperature of 60-80 ℃ while stirring to obtain a B phase mixture;
s4, C phase preparation: pouring the weighed dipropylene glycol, betaine, emollient, skin conditioner I, panthenol, skin conditioner II, tetrahydro-methyl pyrimidine carboxylic acid, hydrolyzed collagen, sodium hyaluronate, disodium EDTA, polyacrylate cross-linked polymer, p-hydroxyacetophenone, bergamot fruit oil and half water into another water phase pot, and stirring and heating the mixture at the constant temperature of 65-85 ℃ until the mixture is completely mixed to obtain a C-phase mixture;
s5, three-phase mixing: and quickly pouring the mixture of the phase A and the mixture of the phase B into the mixture of the phase C, vigorously stirring to form emulsion, continuously and slowly stirring and cooling to 40-50 ℃, adding the residual water, continuously stirring and cooling to room temperature, and standing and aging at the temperature of 20-30 ℃ for 2-4 days to obtain the essence cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010509153.4A CN113749954A (en) | 2020-06-07 | 2020-06-07 | Essence cream and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010509153.4A CN113749954A (en) | 2020-06-07 | 2020-06-07 | Essence cream and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113749954A true CN113749954A (en) | 2021-12-07 |
Family
ID=78785226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010509153.4A Pending CN113749954A (en) | 2020-06-07 | 2020-06-07 | Essence cream and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113749954A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115120532A (en) * | 2022-08-19 | 2022-09-30 | 厦门海马化妆品有限公司 | Skin-care cream and preparation method thereof |
| WO2024014311A1 (en) * | 2022-07-12 | 2024-01-18 | L'oreal | Cosmetic composition comprising selected oil and diol |
| FR3138871A1 (en) * | 2022-08-18 | 2024-02-23 | L'oreal | COMPOSITION INCLUDING SELECTED OIL AND DIOL |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108524344A (en) * | 2017-03-01 | 2018-09-14 | 广州佰盛利和化妆品有限公司 | A kind of penetrating white formula of purification containing lemon and its preparation process |
-
2020
- 2020-06-07 CN CN202010509153.4A patent/CN113749954A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108524344A (en) * | 2017-03-01 | 2018-09-14 | 广州佰盛利和化妆品有限公司 | A kind of penetrating white formula of purification containing lemon and its preparation process |
Non-Patent Citations (2)
| Title |
|---|
| 美歆然化妆品（上海）有限公司: "《C.Miniata胶原凝时修护精华霜》", 22 September 2019, 国家药品监督管理局 * |
| 裘炳毅等: "《现代化妆品科学与技术》", 31 March 2016, 中国轻工业出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024014311A1 (en) * | 2022-07-12 | 2024-01-18 | L'oreal | Cosmetic composition comprising selected oil and diol |
| FR3138871A1 (en) * | 2022-08-18 | 2024-02-23 | L'oreal | COMPOSITION INCLUDING SELECTED OIL AND DIOL |
| CN115120532A (en) * | 2022-08-19 | 2022-09-30 | 厦门海马化妆品有限公司 | Skin-care cream and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113749954A (en) | Essence cream and preparation method thereof | |
| US5254331A (en) | Skin cream composition | |
| CN108524377A (en) | A kind of lightening compositions and its face cream | |
| CN110200845A (en) | It is a kind of for the skin care item for repairing sensitive skin of releiving | |
| CN110721104B (en) | Whitening cream and preparation method thereof | |
| CN108309829A (en) | Skin care milk and preparation method thereof containing camellia seed oil | |
| CN106726994A (en) | A kind of antiallergic is releived cream and preparation method thereof | |
| CN108309831A (en) | Face cream and preparation method thereof containing camellia seed oil | |
| CN109172388A (en) | Ceramide III containing liposome has anti-aging, the facial mask liquid of sebum barrier reparation and preparation method thereof | |
| CN109793695A (en) | A kind of skin barrier repair cream and preparation method thereof | |
| CN108379141A (en) | A kind of antiallergic cosmetic composition and preparation method thereof | |
| WO2021208410A1 (en) | Skin whitening, firming and moisturizing face cream and preparation method therefor | |
| CN109381356A (en) | A kind of sleep late frost and preparation method thereof | |
| CN110496072A (en) | A kind of vibration massage function eye cream of the filtrate containing glossy ganoderma fermentation and preparation method thereof | |
| CN110302091B (en) | Composition containing nicotinamide adenine dinucleotide for resisting skin aging and preparation method and application thereof | |
| CN108066209A (en) | A kind of whitening and spot eliminating cream and preparation method thereof | |
| CN114732753A (en) | Blue copper peptide face cream and preparation method thereof | |
| CN114053201A (en) | Composition for strongly repairing damaged skin lipid membrane and preparation method and application thereof | |
| CN110279633A (en) | A kind of maintenance frost formula and preparation method thereof containing food plant | |
| CN110063923A (en) | A kind of anti-inflammatory Shu Min repair latex containing Golden flower | |
| CN109260086B (en) | Anti-wrinkle essence, preparation method and application thereof | |
| CN115068389B (en) | Multi-effect composition, essence cream and preparation method thereof | |
| CN111632008A (en) | CBD hemp essence emulsion and preparation method thereof | |
| CN111346028A (en) | Multi-effect repairing anti-wrinkle composition, preparation method thereof and multi-effect repairing anti-wrinkle emulsion | |
| CN106727100A (en) | A kind of anti-acne cream composition, acne eliminating cream and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211207 |